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Objectives: Percutaneousmechanical thrombectomy (PMT) is a popu-
lar and useful tool for thrombus removal in acute thrombotic syndromes. The
AngioJet uses high-pressure spray to break up and aspirate thrombus in addi-
tion to delivering plasminogen activators. This is known to cause hemolysis,
and all practitioners have noted periprocedural hematuria. Despite this, to
our knowledge, there is no study evaluating the consequences to renal function
after using this device. We sought to determine the incidence of acute kidney
injury, and associated risk factors after using the AngioJet for thrombolysis.
Methods: With Investigational Review Board approval, we retrospec-
tively reviewed a prospectively maintained database of all patients managed
by the vascular surgery service from 2009-2012 with procedural codes
describing thrombolysis (Current Procedural Terminology [CPT] codes
37201, 37187, 37209, and 75898), and/or PMT (CPT 37187). We iden-
tiﬁed those treated with the AngioJet and reviewed demographics, indica-
tions, laboratory values before and after the procedure (up to 3 days), and
determined the incidence of acute kidney injury (AKI). AKI was deﬁned
as an increase in creatinine (Cr) >25% of baseline within 24 to 72 hours.
Patients on dialysis before AngioJet or without laboratory values before
and 24 to 72 hours after treatment were excluded.
Results: We identiﬁed 144 lysis procedures, and 53 were treated with
the AngioJet. Average age was 50 (range, 87-20; median, 49). Arterial
thrombus was the indication in 68%; venous in the rest. AKI occurred in 15Table. Multivariate analysis of preoperative factors affecting outcomes with low
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BMI, Body mass index; CAD, coronary artery disease; CI, conﬁdence interval; Cof 53 (28%). Baseline Cr in AKI and non-AKI patients was similar, whereas
Cr after AngioJet was not (P ¼ .01). Only four patients had a baseline Cr
>1.4 (two in each group). Average age of the AKI group was 54 (range 36-
74, medium 49), 47% were male, and only one had a baseline Cr >1.4 mg/
dL (not signiﬁcant for all). Average creatinine increase from baseline in AKI
group was 0.5 mg/dL (167% rise; P ¼ .003) compared with e0.07mg/dL
(NS) in non-AKI patients. When compared with 53 lysis cases that did not
use AngioJet, the Cr change in the AngioJet group was higher (P ¼ .03).
Conclusions: This preliminary study suggests that AKI may occur in
more than one-quarter of patients treated with the AngioJet, independently of
traditional risk factors for AKI (diabetes, baseline Cr, and age). This risk may
be due to hemolysis and is under-reported in the literature. Prospective studies
and long-term consequences should be undertaken to better deﬁne this risk.
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Objectives: We have previously reported trends of decreasing amputa-
tions along with increasing endovascular interventions for peripheral arterial dis-
ease (PAD) in a deﬁned population between 1990 and 2009. The aim of this
studywas to analyzepreoperative risk factors affectingoutcomes in thesepatients.
Methods: A retrospective cohort study of residents of a single
county was conducted. Procedures were identiﬁed by International Clas-
siﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-
CM)/Current Procedural Terminology codes and data collecteder extremity revascularization procedures
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OPD, chronic obstructive pulmonary disease; HR, hazard ratio.
